drugset / Trial / NCT03400995
A Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of AK0529
NaSingle-groupOpen-labelTreatment
Summary
This phase I study is to assess the mass balance recovery after a single oral dose of \[14C\]-AK0529 in healthy male subjects.
Timeline
- Start
- 2018-01-05
- Primary completion
- 2018-02-27
- Completion
- 2018-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ziresovir | Small molecule | 300 mg | Oral |
Indications
No indication recorded.